drugset / Trial / NCT03825887
Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Evaluation of safety and efficacy of Nalbuphine versus Morphine patient controlled analgesia (PCA) for mucositis pain in pediatric cancer patients
Timeline
- Start
- 2018-02-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | 10 ug/kg | — |
| Subject | Nalbuphine | Small molecule | 10 ug/kg | — |